The 3rd Scientific Meeting on Hypertension

The Ritz Calton Hotel Jakarta Feb 28 - March 01, 2009

Scientific Program

Saturday, February 28, 2009

07.00 - 08.00 Registration

PLENARY SESSION I

08.00 - 08.30 Hypertension in Indonesia : From epidemiology point of view.

08.30 - 09.00 The Updated evidences on hypertension management.

09.00 - 09.30 OPENING CEREMONY.

09.30 - 10.00 Coffee break

SYMPOSIUM I

Thrombogenesis in hypertension

10.00 - 10.20 Hypertension and blood coagulation : review on biomolecular mechanism.

10.20 - 10.40 Stroke prevention and bleeding risk in atrial fibrillation

10.40 - 11.00 Dual antiplatelet in post acute coronary syndrome – For how long?

11.00 – 11.15 Discussion

SYMPOSIUM 2

Preventring cerebrovascular event in hypertension

10.00 - 10.20 In hypertension treatment : Is anti-thromobotic agent a necessity?

10.20 - 10.40 Low dose aspirin: Realizing the potential.

10.40 - 11.00 Hypertension guidelines: A new perspective and a better direction for cerebrovascullar disease prevention

11.00 – 11.15 Discussion

LUNCH SYSMPOSIUM I

New approach in hypertention management

11.15 - 11.35 Paradigm shift in drugs treatment of hypertension: From titration to combination.

11.35 - 11.55 Direct Renin Inhibitor: A novel approach to BP control and organ protection.

11.55 - 12.15 Discussion

LUNCH SYSMPOSIUM 2

The role of angiotensin receptor blockers (ARBs) and thiazolidinediones in the management of organ protection

11.15 - 11.35 Management of coronary artery disease in diabetic patients

11.35 - 11.55 Managing high risk hypertensive patients: the role of ARB in cardiovascular protection.

11.55 - 12.15 Discussion

12.15 - 13.15 LUNCH

SYSMPOSIUM 3

Holistic approach in the management of cardiovascular risk

13.15 - 13.35 How to manage diabetic in high risk hypertension

13.35 - 13.55 Looking beyond blood pressure control.

13.55 - 14.15 New approach for cardiovascular risk managenent

14.15 - 14.30 Discussion

SYSMPOSIUM 4

Manipulating RAA system in hypertension

13.15 - 13.35 Combination of ACE inhibitor and ARB: Good or bad?

13.35 - 13.55 ONTARGET/TRANSCEND results: New proof in cardiovascular protection..

13.55 - 14.15 ONTARGET results focus on Asian population: Implication for hypertensive ‘high risk’ patients?

14.15 - 14.30 Discussion

14.30 - 15.30 MEET THE EXPERT

“Hypertension in Asia countries: The problems and the strategies in reducing cardiovascular morbidity and mortality”

19.00 - Selesai DINNER SYMPOSIUM

“MAXIMIZING THE STRATEGY IN ATHEROTHROMBOTIC DISEASES”

19.00 - 19.15                The Future Role of Antiplatelet Agents in Cardiovascular Diseases

19.15 - 19.30                Atherothrombotic Stroke Prevention with Antiplatelet Agents : Any Clinical Issues?

===================================

Workshop on

Ambulatory Blood Pressure Monitoring

Date : Saturday, February 28, 2009

Time : 14.50 WIB

LIMITED for 40 participants only

=====================================

Sunday, March 1, 2009

BREAKFAST SYMPOSIUM

Better understanding of beta blocker on hypertension management

07.30 - 07.55 Are we misunderstanding beta blocker on hypertension management: Focus on bisoprolol

07.55 - 08.10 The rational of low dose combination as a logical and effective first line anti hypertension drug

08.10 - 08.30 Discussion

PLENARY SESSION 2

08.30 - 08.50 Pharmaco-economics and quality of life in hypertension treatment.

08.50 - 09.10 The arterial system in hypertension: The detection, importance and influence in therapy .

09.10 - 09.30 Discussion

SYMPOSIUM 5

Hypertension management highlight: Optimizing target organ perfusion

09.30 - 09.50 Effect of vasoactive therapy on cerebral circulation.

09.50 - 10.10 New paradigm: Role of new ARB in pulse pressure and systolic blood pressure controlling.

10.10 - 10.30 New approach of sustained control of blood pressure for cardiovascular protection

10.30 – 10.45 Discussion

SYMPOSIUM 6

Management of hypertension and target organ protection

09.30 - 09.50 Vascular calcification: The reasons and the mechanisms

09.50 - 10.10 The role of beta blocker in the treatment of hypertension: Strategy for better outcome

10.10 - 10.30 The rationale combination therapy in hypertension to avoid target organ damage: Focus on ACE inhibitor and calcium channel blocker

10.30 – 10.45 Discussion

10.45 - 11.15 Coffee break

LUNCH SYSMPOSIUM 3

The latest morbid-mortality trials on ACE inhibitor and diuretic combination in high risk patients

11.15 - 11.30 AVANCE results : Life saving benefits of fixed dose combination of ACE and indapamide in diabetic patients with or without hypertension

11.30 - 11.45 New era in the management of very elderly hypertensive patients: A lessons from HYVET study .

11.45 - 12.15 Discussion

LUNCH SYSMPOSIUM 4

Hypertension: I-PRESERVE result

11.15 - 11.30 Heart failure with preserved ejection fraction: New evidence from I-PRESERVE study

11.30 - 11.45 Combination therapy of ARB and thiazide diuretic in uncomtrolled hypertension and risk patients: What is new? .

11.45 - 12.15 Discussion

12.15 - 13.15 LUNCH

SYMPOSIUM 7

Comprehensive approach in hypertension management

13.15 - 13.55 Meet the expert

13.35 - 14.15 Discussion

SYMPOSIUM 8

Pitfalls in hypertension crisis

13.15 - 13.35 Current management of hypertensive crisis

13.35 - 13.55 Debate interdiciplines in hypertension crisis management..

13.55 - 14.15 Discussion

14.15 - finish InasH Consensus “Hypertension special Population”

Launching and distribution